Figure 6 | Leukemia

Figure 6

From: CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients

Figure 6

Kaplan–Meier estimates of overall survival in patients of the Italian series belonging to the IPSS11 intermediate-2- and high-risk category (n=92) stratified according to the mutational status of CALR and ASXL1. The three tiers included CALR+/ASXL1 (n=11), CALR/ASXL1+ (n=28) and CALR/ASXL1 or CALR+/ASXL1+ (n=53). The different survival curves were trend significant, P=0.07 The HR is presented together with the 95% CI, using CALR+/ASXL1 as the reference population (HR=1.0).

Back to article page